Hematopoietic cell transplantation has gained attention for its potential in treating joint pain and conditions that standard methods fail to alleviate. Combining this method with amniotic stem cells and platelet-rich plasma (PRP) may hold exceptional promise in regenerating joints.
Amniotic stem cells, which can develop into various tissue types, need a conducive environment for growth, such as a well-supplied blood flow. A PRP injection extracted from a person’s blood provides the growth factors required for directing stem cells in the process of tissue repair and regeneration. This combination of amniotic stem cells and PRP may be the perfect recipe for regenerating non-healing joints or tendons in various parts of the body, without resorting to costly surgery.
Stem cell therapy has also shown potential in reversing symptoms of age-associated frailty. Two recent human clinical trials suggested that stem cell therapy safely improved all parameters studied relating to frailty, including physical performance, measurements of immunity blood markers, and female sexual quality of life. If larger clinical trials and a phase 3 clinical trial replicate these findings, stem cell infusions could become part of mainstream medicine for treating age-related frailty. Stem cell research may take us closer to natural therapies that can reverse illness and promote healing.
